Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-29 @ 9:22 AM
Study NCT ID:
NCT06908304
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-25
First Post:
2025-03-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Sponsor:
Maia Biotechnology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-07-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-29
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-20
First Submit QC Date:
None
Study First Post Date:
2025-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-22
Last Update Post Date:
2025-09-25
Last Update Post Date Type:
ESTIMATED